Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

FDA grants fast track designation to new drug for Friedreich's ataxia cardiomyopathy
The new gene therapy candidate is now one step closer to being approved by the FDA.
CT procedure shown to reduce need for invasive cardiac testing
In a study, CT-FFR was shown to reduce the need for invasive tests to measure coronary artery blockage from 74.5% to 25.5%.
$Performing CT-derived fractional flow reserve (CT-FFR) before transcatheter aortic valve replacement (TAVR) improves the accuracy of coronary CT angiography (CCTA) and helps limit unneeded invasive coronary angiography (ICA), according to a new study published in JACC: Cardiovascular Interventions. Heartflow$
New cardiac imaging strategy could reduce ICA, PCI rates
Radiologists with Massachusetts General Hospital found that the selective use of cardiac CT and AI-based CAD evaluations could make a significant impact on patient care.
PHOTO GALLERY: Highlights from ACC.24 in Atlanta
ACC.24, the American College of Cardiology's annual meeting in Atlanta, featured the latest in cardiovascular research and technologies. Representatives from Cardiovascular Business were there in person to take in the excitement.
First-in-human trial shows potential of guiding CABG with cardiac CT and AI—no ICA required
An independent heart team blinded to ICA results was able to deliver helpful guidance for CABG procedures for 99.1% of patients using just CCTA and FFR_CT alone. This approach is safe and feasible, researchers wrote, and the next step is to gather additional data.

FDA grants fast track designation to new drug for Friedreich's ataxia cardiomyopathy

The new gene therapy candidate is now one step closer to being approved by the FDA.

April 17, 2024

CT procedure shown to reduce need for invasive cardiac testing

In a study, CT-FFR was shown to reduce the need for invasive tests to measure coronary artery blockage from 74.5% to 25.5%.

April 16, 2024

$Performing CT-derived fractional flow reserve (CT-FFR) before transcatheter aortic valve replacement (TAVR) improves the accuracy of coronary CT angiography (CCTA) and helps limit unneeded invasive coronary angiography (ICA), according to a new study published in JACC: Cardiovascular Interventions. Heartflow$

New cardiac imaging strategy could reduce ICA, PCI rates

Radiologists with Massachusetts General Hospital found that the selective use of cardiac CT and AI-based CAD evaluations could make a significant impact on patient care.

April 16, 2024

The V-Wave intra-atrial shunt to treat heart failure on display on the expo floor at ACC.24. The device was used in one of the late breaking trials at ACC. DF 3

PHOTO GALLERY: Highlights from ACC.24 in Atlanta

ACC.24, the American College of Cardiology's annual meeting in Atlanta, featured the latest in cardiovascular research and technologies. Representatives from Cardiovascular Business were there in person to take in the excitement.

April 16, 2024

First look at data on Biosense Webster Dual Energy THERMOCOOL SMARTTOUCH SF platform for atrial fibrillation presented at EHRA Congress

The Dual Energy THERMOCOOL SMARTTOUCH SF Catheter is the first dual energy pulsed field (PF) ablation / radiofrequency (RF) ablation catheter integrated with a PF and RF ablation index.

April 10, 2024

First-in-human trial shows potential of guiding CABG with cardiac CT and AI—no ICA required

An independent heart team blinded to ICA results was able to deliver helpful guidance for CABG procedures for 99.1% of patients using just CCTA and FFR_CT alone. This approach is safe and feasible, researchers wrote, and the next step is to gather additional data.

April 10, 2024

ACC.24: New data suggest early PCI limits risks of vulnerable plaques—cardiologists are skeptical

The PREVENT study, presented at ACC.24, examined more than 1,600 patients with high-risk plaques treated with either preventive PCI or medical therapy alone. Outcomes were much better for the PCI group after two years, but the findings may lead to more questions than answers.

April 9, 2024

For almost nine years since the adoption of the Protecting Access to Medicare Act (PAMA) established the requirement for appropriate use criteria (AUC) to receive payment for advanced diagnostic imaging, the American Society of Nuclear Cardiology (ASNC) has lobbying Congressional leaders change or repeal AUC mandate. Those efforts have paid off in the 2024 Medicare Physician Fee Schedule final rule, where AUC program has been paused and all of its regulations were rescinded. Photo by Dave Fornell.

Medicare drops AUC requirement for advanced imaging, ASNC celebrates

"This was an unneeded burden, which was solely adding to the administrative hassles of medicine," said American Society of Nuclear Cardiology President Larry Phillips.

April 8, 2024